Skip to main content
SpringerLink
Log in

Effect of Fingolimod-Treatment on Blood Lipid Profiles of Multiple Sclerosis Patients

  • LETTER TO THE EDITOR
  • Published:
Journal of Neuroimmune Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Borodulin K, Vartiainen E, Peltonen M, Jousilahti P, Juolevi A, Laatikainen T, Männistö S, Salomaa V, Sundvall J, Puska P (2015) Forty-year trends in cardiovascular risk factors in Finland. Eur J Pub Health 25(3):539–546 Epub 2014 Nov 24

    Article  Google Scholar 

  • Huang K, Li SQ, Wang WJ, Liu LS, Jiang YG, Feng PN, Wang YQ, Wang SM (2012) Oral FTY720 adminstration induces immune tolerance and inhibits early development of atherosclerosis in apolipoprotein E-deficient mice. Int J Immunopathol Pharmacol 25(2):397–406

    CAS  PubMed  Google Scholar 

  • Kappos L, Radue EW, O'Connor P, Polman C, Hohlfeld R, Calabresi P, Selmaj K, Agoropoulou C, Leyk M, Zhang-Auberson L, Burtin P, FREEDOMS Study Group (2010) A placebo-controlled trial of oral fingolimod. N Engl J Med 362(5):387–401 Epub 2010 Jan 20

  • Klingenberg R, Nofer JR, Rudling M, Bea F, Blessing E, Preusch M, Grone HJ, Katus HA, Hansson GK (2007) Dengler TJ (2007) sphingosine-1-phosphate analogue FTY 720 causes lymphocyte Redistribution and hypercholesterolemia in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 27(11):2392–2399 Epub 2007 Aug 30

    Article  CAS  PubMed  Google Scholar 

  • Nofer JR, Bot M, Brodde M, Taylor PJ, Salm P, Brinkmann V, van Berkel T, Assmann G, Biessen EA (2007) FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of early atherosclerosis in low-density lipoprotein-deficient mice. Circulation 115:501–508 Epub 2007 Jan 22

    Article  CAS  PubMed  Google Scholar 

  • Simula S, Laitinen T, Laitinen, T.M., Tarkiainen T, Hartikainen, J.E.K., Hartikainen P (2015) Effects of three months fingolimod therapy on heart rate. J Neuroimmune pharm 10:651–654. Epub 2015 June 20.

Download references

Author information

Authors and Affiliations

  1. Turun Yliopisto, Turku, Finland

    Anni Hovi & Laura Airas

Authors
  1. Anni Hovi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura Airas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anni Hovi.

Ethics declarations

Conflict of Interest

The Authors declare that there is no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hovi, A., Airas, L. Effect of Fingolimod-Treatment on Blood Lipid Profiles of Multiple Sclerosis Patients. J Neuroimmune Pharmacol 11, 611–612 (2016). https://doi.org/10.1007/s11481-016-9697-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11481-016-9697-2

Keywords

Search

Navigation